CORT Latest Headlines

Genmab rises, Corcept falls on late-stage antibody-conjugate data for ovarian cancer

at seekingalpha.com (Fri, 23-Oct 3:27 PM)

Corcept rallies as EU panel backs relacorilant for platinum-resistant ovarian cancer, with EC decision eyed in Q4 2026

Market Chameleon (Mon, 21-Sep 11:39 AM)

Corcept gains EU regulatory momentum as CHMP backs relacorilant combo for platinum-resistant ovarian cancer

Market Chameleon (Fri, 18-Sep 10:27 AM)

Corcept Therapeutics Ups 2026 Revenue Guidance as Lifyorli Launch Accelerates Growth

Market Chameleon (Thu, 30-Jul 11:13 AM)

Corcept Therapeutics Lifts 2026 Revenue Guidance on Strong Product Launches and Expanding Clinical Pipeline

Market Chameleon (Thu, 30-Jul 7:06 AM)